Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Cancer Res. 2010 Mar 23;70(7):2789–2798. doi: 10.1158/0008-5472.CAN-09-3541

Table 3.

Target SNP association with disease status.

SNP (gene) (SPORADIC+FAMILIAR) vs CONTROL FAMILIAR vs CONTROL SPORADIC vs CONTROL FAMILIAR vs SPORADIC
OR (95% CI)* p value OR (95% CI)* p value OR (95% CI)* p value OR (95% CI)* p value
rs334348 (TGFBR1) AG vs AA 1.69 (1.01, 2.83) 0.048 2.2 (1.29, 4.07)
2.67 (1.19, 6.03)
0.005
0.002
1.15 (0.63, 2.11) 0.65 1.99 (1.15, 3.46)
2.17 (1.15, 4.07)
0.01
0.02
GG vs AA 0.71 (0.26, 1.99) 0.52 0.46 (0.11, 1.86) 0.27 0.94 (0.31, 2.88) 0.92 0.48 (0.12, 1.97) 0.31
rs799917 (BRCA1) CT vs CC 1.57 (1.04, 2.37)
1.86 (1.01, 3.42)
0.03
0.046
1.25 (0.76, 2.05) 0.38 1.98 (1.20, 3.26) 0.007 0.63 (0.36, 1.10) 0.1
TT vs CC 1.95 (1.06, 3.6) 0.03 1.26 (0.59, 2.71) 0.55 2.81 (1.40, 5.64) 0.003 0.45 (0.21, 0.97) 0.04
*

Odds Ratio according to univariate and to multivariate (adjusted for age) logistic regression model, first and second row respectively. Only OR from statistically significant multivariate logistic regressions are shown.